Exelixis
Sign in to saveExelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Company
EXEL- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- Nasdaq
- State of incorporation
- DE
- Entity type
- operating
- Fiscal year end
- Jan 1
via SEC EDGAR
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1994
- Location
- South San Francisco, United States
- Status
- Active
GRID grid.428377.d · ISNI 0000 0004 0465 1644
Official website
Shaping the Future of Oncology for Patients l Exelixis
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
exelixis.com →Link to the official site · 6,652 chars · not written by Vinony
~7 min read
Encyclopedic overview
6 sectionsContents
- History
- Finance
- Pricing
- Cabometyx (cabozantinib)
- External links
- References
Innovating medicine brings hope
Excerpted from Wikipedia’s “Exelixis” article, available under the CC BY-SA 4.0 licence.